6922 — Cryofocus Medtech (Shanghai) Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.47bn
- HK$1.44bn
- CNY53.53m
Annual cashflow statement for Cryofocus Medtech (Shanghai) Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -159 | -126 | -118 | -106 | -111 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 111 | 67.3 | 17.9 | 19.4 | 26.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 11.2 | -7.76 | -4.2 | -18.9 | -10.1 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -34.2 | -62.5 | -96.9 | -95.9 | -82.9 |
| Capital Expenditures | -1.51 | -12.5 | -7.01 | -15.1 | -1.88 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 28.5 | 28.2 | 0.463 | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 27 | 15.7 | -6.55 | -15.1 | -1.88 |
| Financing Cash Flow Items | 0 | -4.37 | -15.2 | -8.24 | -0.389 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.608 | 198 | 169 | -13.7 | 25.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.89 | 150 | 68.6 | -123 | -57.9 |